Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
KIND Announces FDA Granted Orphan Drug Designation (ODD) for AND017 in the Treatment of Sickle Cell Disease (SCD) 2024-10-26 00:33
Lifezoom Unveils Next-Gen 3-in-1 Handheld Red Light Therapy Wand - Transform Your Skincare Routine 2024-10-25 21:00
WOORIEN launches 'MyVet CT Plus': Advanced Veterinary imaging Solution 2024-10-25 21:00
LakeShore Biopharma Granted Phase III Clinical Trial Approval to Explore Simplified Regimens for YSJA Rabies Vaccine 2024-10-25 20:30
Prudential launches first-in-market insurtech solutions MedScreen+ with Reinsurance Group of America 2024-10-25 20:12
MicuRx Announces the Successful Completion of Phase 1 Clinical Trial of MRX-5 in Australia 2024-10-25 19:29
Corvia Medical Announces Three-Year Clinical Trial Results Confirming Significant and Durable Benefits of the Corvia Atrial Shunt in Heart Failure Patients 2024-10-25 19:20
Brinc Hosts Its 4th Successful Asia Health Innovation Summit 2024, as Part of StartmeupHK Festival, Curated by InvestHK 2024-10-25 18:34
Global Times: Chinese insurers pursue innovative programs to shore up elderly care 2024-10-25 18:20
Ribbon of Hope: A Collaborative Cancer Support Initiative by BIG Pharmacy and CARiNG Pharmacy 2024-10-25 15:25
TASTE-2 World Stroke Congress | Sanbexin ® combined with thrombectomy significantly reduces stroke disability 2024-10-25 15:14
HiConf Seoul 2024 successfully wraps up, sparks up discussions for future of food tech and international partnerships 2024-10-25 10:39
Everest Medicines Announces the Launch of VELSIPITY® in the Guangdong-Hong Kong-Macau Greater Bay Area, Offering a New Option for Moderately to Severely Active Ulcerative Colitis Patients 2024-10-25 07:40
Volpara Health Surpasses 300 Peer-Reviewed Papers 2024-10-25 00:00
Shaklee, A Leader in Clean Wellness and Skincare, Expands into Australia 2024-10-24 22:03
Frost & Sullivan Honors Industry Leaders with Prestigious 2024 Best Practices Awards 2024-10-24 22:00
EpiVax and CUBRC Awarded FDA Contract Worth $2M for Development of Control Peptides for Immunogenicity Risk Assessment Assays Supporting Regulatory Filings of Generic Peptide Drugs 2024-10-24 21:05
IMG Announces 2024 Leave Your Mark Grant Winners 2024-10-24 21:00
Innovation at the Forefront: Angel Yeast Shines at FHA 2024 2024-10-24 20:30
Besmile Announces RMB 1 Million Donation to Support Shanghai 9th People's Hospital's Dental Service Development 2024-10-24 20:20
1 14 15 16 17 18 1624